HIVEC® Treatment Rivals BCG in New Clinical Trial
Combat is committed to investing in research and development, clinical trials and evidence-based studies to prove the efficacy of its technology and create a solid foundation for use. Over 1000 patients are currently in clinical trials and in excess of 2000 treatments are given to patients each month.
Combat works closely with healthcare professionals worldwide and partners with a global network of distributors to ensure that its devices are available to bladder and peritoneal cancer patients in as many countries as possible.
All healthcare professionals resources